Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 Q4- Text added to 2014 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Africa, alliance, Ankeny, AppTec, AU, aversion, batch, begun, billion, Biomedical, built, card, condensed, convenience, convince, counteract, deliverable, divest, Dohme, DOI, double, DSMC, DTRA, EJ, epidemic, familiarity, Gastrointest, Genentech, glycoprotein, GRRI, Hardacre, hemorrhagic, Henneman, holder, Hong, identification, ISU, JM, John, JRC, JSC, KA, Kong, leader, licensee, maker, margin, microenvironment, mulcahy, NG, nivolumab, nonrefundable, Opdivo, optimal, persuasive, PHAC, pivotal, predetermined, prime, Ready, reconciling, Schema, Sharpe, shift, shipment, shortly, solved, stand, standalone, steering, stockpile, stoppage, taxane, TDO, temozolomide, thereon, Threat, tiered, unearned, unprofitable, variable, vector, VHF, VSV, warehousing, West, WuXi, Xalkori, Zenaca
Removed:
account, adding, AICPA, Aid, aim, arriving, AstraZeneca, attainment, Bavarian, biosimilar, bone, calculable, California, carboplatin, carcinoma, carryout, cerebrovascular, choice, chronic, colon, combat, combining, compounding, computation, computed, concentrating, construction, cryopreservative, denominator, diminish, diminished, DOD, driven, Eloxatin, empirically, employ, employing, enabled, enterprise, estrogen, execution, Florida, Francisco, Gastroenterology, Gemzar, generically, GHS, GHSURI, gland, goal, Gordon, guideline, harmonized, hormonal, immunologic, improving, inducing, informal, Investigate, Iressa, irradiating, irritation, ischemia, kidney, Majesty, mammography, measurement, metastasized, mitomycin, mitotic, modeling, Moffitt, nephrectomy, NIH, Nordic, nutrient, outlined, outlook, ovarian, pediatric, Picozzi, pituitary, preliminary, protein, Queen, receptor, recurred, recurrence, relief, repaid, replacement, San, scalable, screening, selection, sensitized, SIGA, signaling, simpler, solution, sooner, specialist, standardized, Story, streptozocin, suitable, swelling, Tampa, Teva, treatable, unchanged, venorelbine, VP, yellow
Valuein 2013 Q4 filing- Value in 2014 FY filing
Original filings
Filing view